PB 19 of 2013
National Health (Listed drugs on F1 or F2) Amendment Determination 2013 (No. 2)1
National Health Act 1953
I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the
Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.
Dated 27 March 2013
ADRIANA PLATONA
Assistant Secretary
Pharmaceutical Evaluation Branch
Pharmaceutical Benefits Division
Department of Health and Ageing
Part 1 Preliminary
1 Name of Determination
(1) This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2013 (No. 2).
(2) This Determination may also be cited as PB 19 of 2013.
2 Commencement
This Determination commences on 1 April 2013.
3 Amendment of National Health (Listed drugs on F1 or F2) Determination 2010
Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).
Schedule 1 Amendments
(Section 3)
[1] Schedule 1, after item dealing with Bivalirudin
Insert
Boceprevir
[2] Schedule 1, after item dealing with Calcium
Omit
Candesartan
[3] Schedule 1, after item dealing with Desmopressin
Omit
Desvenlafaxine
[4] Schedule 1, after item dealing with Domperidone
Omit
Donepezil
[5] Schedule 1, after item dealing with Doxorubicin, peglyated liposomal
Omit
Duloxetine
[6] Schedule 1, after item dealing with Epoprostenol
Omit
Eprosartan
[7] Schedule 1, after item dealing with Interferon beta-1a
Omit
Interferon Beta-1b
[8] Schedule 1, after item dealing with Interferon gamma-1b
Omit
Irbesartan
[9] Schedule 1, after item dealing with Lithium
Omit
Losartan
[10] Schedule 1, after item dealing with Ofloxacin
Omit
Olmesartan
[11] Schedule 1, after item dealing with Rosiglitazone
Insert
Rotigotine
[12] Schedule 1, after item dealing with Tadalafil
Insert
Telaprevir
[13] Schedule 1, after item dealing with Telbivudine
Omit
Telmisartan
[14] Schedule 1, after item dealing with Triptorelin
Omit
Tropisetron
[15] Schedule 1, after item dealing with Valine with carbohydrate
Omit
Valsartan
[16] Schedule 2, after item dealing with Calcitriol
Insert
Candesartan
[17] Schedule 2, after item dealing with Desferrioxamine
Insert
Desvenlafaxine
[18] Schedule 2, after item dealing with Docetaxel
Insert
Donepezil
[19] Schedule 2, after item dealing with Doxycycline
Insert
Duloxetine
[20] Schedule 2, after item dealing with Epirubicin
Insert
Eprosartan
[21] Schedule 2, after item dealing with Indomethacin
Insert
Interferon beta-1b
[22] Schedule 2, after item dealing with Ipratropium
Insert
Irbesartan
Irbesartan with Hydrochlorothiazide
[23] Schedule 2, after item dealing with Loperamide
Insert
Losartan
[24] Schedule 2, after item dealing with Olanzapine
Insert
Olmesartan
[25] Schedule 2, after item dealing with Tamoxifen
Insert
Telmisartan
[26] Schedule 2, after item dealing with Trimethoprim with sulfamethoxazole
Insert
Tropisetron
[27] Schedule 2, after item dealing with Valproic acid
Insert
Valsartan
Note
1. All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See http://www.comlaw.gov.au.
